Zusev Margalit, Benayahu Dafna
Department of Cell and Developmental Biology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
PLoS One. 2009 Jul 28;4(7):e6407. doi: 10.1371/journal.pone.0006407.
This study provides a novel view on the interactions between the MS-KIF18A, a kinesin protein, and estrogen receptor alpha (ERalpha) which were studied in vivo and in vitro. Additionally, the regulation of MS-KIF18A expression by estrogen was investigated at the gene and protein levels. An association between recombinant proteins; ERalpha and MS-KIF18A was demonstrated in vitro in a pull down assay. Such interactions were proven also for endogenous proteins in MBA-15 cells were detected prominently in the cytoplasm and are up-regulated by estrogen. Additionally, an association between these proteins and the transcription factor NF-kappaB was identified. MS-KIF18A mRNA expression was measured in vivo in relation to age and estrogen level in mice and rats models. A decrease in MS-KIF18A mRNA level was measured in old and in OVX-estrogen depleted rats as compared to young animals. The low MS-KIF18A mRNA expression in OVX rats was restored by estrogen treatment. We studied the regulation of MS-KIF18A transcription by estrogen using the luciferase reporter gene and chromatin immuno-precipitation (ChIP) assays. The luciferase reporter gene assay demonstrated an increase in MS-KIF18A promoter activity in response to 10(-8) M estrogen and 10(-7)M ICI-182,780. Complimentary, the ChIP assay quantified the binding of ERalpha and pcJun to the MS-KIF18A promoter that was enhanced in cells treated by estrogen and ICI-182,780. In addition, cells treated by estrogen expressed higher levels of MS-KIF18A mRNA and protein and the protein turnover in MBA-15 cells was accelerated. Presented data demonstrated that ERalpha is a defined cargo of MS-KIF18A and added novel insight on the role of estrogen in regulation of MS-KIF18A expression both in vivo and in vitro.
本研究对驱动蛋白MS-KIF18A与雌激素受体α(ERα)之间的相互作用提出了新观点,这些相互作用在体内和体外都进行了研究。此外,还在基因和蛋白质水平上研究了雌激素对MS-KIF18A表达的调控。在体外下拉试验中证实了重组蛋白ERα与MS-KIF18A之间的关联。在MBA-15细胞中也证实了内源性蛋白之间存在这种相互作用,这些相互作用在细胞质中显著检测到,并受雌激素上调。此外,还确定了这些蛋白与转录因子NF-κB之间的关联。在小鼠和大鼠模型中,在体内测量了MS-KIF18A mRNA表达与年龄和雌激素水平的关系。与年轻动物相比,老龄和去卵巢雌激素缺乏大鼠的MS-KIF18A mRNA水平降低。雌激素治疗可恢复去卵巢大鼠中低水平的MS-KIF18A mRNA表达。我们使用荧光素酶报告基因和染色质免疫沉淀(ChIP)试验研究了雌激素对MS-KIF18A转录的调控。荧光素酶报告基因试验表明,响应10(-8)M雌激素和10(-7)M ICI-182,780,MS-KIF18A启动子活性增加。作为补充,ChIP试验定量了ERα和pcJun与MS-KIF18A启动子的结合,在雌激素和ICI-182,780处理的细胞中这种结合增强。此外,雌激素处理的细胞表达更高水平的MS-KIF18A mRNA和蛋白质,并且MBA-15细胞中的蛋白质周转加快。所呈现的数据表明,ERα是MS-KIF18A的一种特定货物,并为雌激素在体内和体外调节MS-KIF18A表达中的作用提供了新的见解。